Dual-Task Training for Balance and Hand Function in Unilateral CP

March 27, 2026 updated by: hanaa mohsen, Badr University

Effect of Dual-task Training Program on Balance and Hand Functions in Unilateral Cerebral Palsy

This trial will evaluate the impact of a dual-task training program on children aged 6-8 years with unilateral cerebral palsy. Seventy participants will be randomized into dual-task and single-task groups, with the dual-task group performing balance exercises while engaging in fine motor tasks. It is expected that dual-task training will produce superior improvements in balance and hand function, offering a safe and effective alternative to traditional single-task methods.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • Badr Univesity in Cairo (BUC)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • - Their age will range from 6 to 8 years.
  • Mild degree of spasticity ranged from 1 to 1+ according to Modified Ashworth Scale
  • Their motor function will be at level I and II according to Gross Motor Function Classification System GMFCS

Exclusion Criteria:

  • - Botulinum toxin injections in the last 6 months.
  • The presence of visual perceptual impairment.
  • Surgical interference in upper, lower limbs and/or spine.
  • Muscloskeletal problems or fixed deformities in the spine and/or upper or/and lower extremities.
  • Seizures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: control
selected rehabilitation program
Other: rehabilitation program
designed rehabilitation program
Experimental: intervention
dual task exercises in the form of balance and hand functions
Other: Dual-Task Training Program
the participant will receive dual task program in form of balance and hand function program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HUMAC Balance
Time Frame: pre and post treatment 3 month
humac balance
pre and post treatment 3 month
Bruininks-Oseretsky
Time Frame: pre and post treatment 3 month
Fine motor Proficiency assessed by Bruininks-Oseretsky
pre and post treatment 3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Badr University

Investigators

  • Principal Investigator: Hanaa M Abd-Elfattah, Associate Professor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2025

Primary Completion (Actual)

January 15, 2026

Study Completion (Estimated)

April 30, 2026

Study Registration Dates

First Submitted

September 11, 2025

First Submitted That Met QC Criteria

September 11, 2025

First Posted (Actual)

September 17, 2025

Study Record Updates

Last Update Posted (Actual)

April 1, 2026

Last Update Submitted That Met QC Criteria

March 27, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • hana 10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Balance

Clinical Trials on rehabilitation program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe